| Aurobindo Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524804 |
NSE Symbol : AUROPHARMA |
P/E(TTM) : 34.31 |
|
ISIN Demat : INE406A01037 |
Div & Yield% : 0.00 |
EPS(TTM) : 34.79 |
|
Book Value(₹) : 369.16 |
Market Cap(₹Cr) : 69,330.29 |
Face Value(₹) : 1.00 |
| Particulars | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 10,933.30 | 10,645.64 | 12,792.28 | 11,287.14 | 15,823.68 |
| Other Income | 328.12 | 670.10 | 433.76 | 670.99 | 589.86 |
| Stock Adjustments | 67.66 | 116.23 | 466.00 | -45.51 | -2.99 |
| Total Income | 11,329.08 | 11,431.97 | 13,692.04 | 11,912.62 | 16,410.55 |
| EXPENDITURE : | |||||
| Raw Materials | 5,675.34 | 5,964.48 | 7,336.92 | 5,800.74 | 7,241.83 |
| Power and Fuel Cost | 185.59 | 191.58 | 613.92 | 477.99 | 512.34 |
| Other Manufacturing Expenses | 426.63 | 414.51 | 650.91 | 705.68 | 925.86 |
| Selling and Administration Expenses | 960.27 | 822.21 | 1,089.33 | 1,009.36 | 1,069.84 |
| Miscellaneous Expenses | 132.49 | 164.49 | 194.40 | 249.13 | 215.57 |
| Employee Benefit Expenses | 1,063.07 | 980.56 | 1,641.88 | 1,600.04 | 1,735.42 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 2,885.69 | 2,894.14 | 2,164.68 | 2,069.68 | 4,709.69 |
| Interest | 230.04 | 182.60 | 114.98 | 16.94 | 28.68 |
| Gross Profit | 2,655.65 | 2,711.54 | 2,049.70 | 2,052.74 | 4,681.01 |
| Depreciation | 297.20 | 254.58 | 435.35 | 415.26 | 488.00 |
| Profit Before Tax | 2,358.45 | 2,456.96 | 1,614.35 | 1,637.48 | 4,193.01 |
| Current Tax | 627.37 | 598.08 | 407.02 | 379.70 | 1,043.34 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -15.71 | -95.26 | -23.08 | -196.93 | 36.76 |
| Reported Net Profit | 1,746.79 | 1,954.14 | 1,230.41 | 1,454.71 | 3,112.91 |
| Extraordinary Items | 5.48 | 1.17 | 9.98 | -81.27 | -0.13 |
| Adjusted Net Profit | 1,741.31 | 1,952.97 | 1,220.43 | 1,535.98 | 3,113.04 |
| Adjustment below Net Profit | -5.26 | -1.69 | 5.87 | 1.69 | -6.42 |
| Profit/Loss Balance carried down | 18,348.87 | 16,660.08 | 15,864.14 | 14,671.41 | 11,799.30 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 263.66 | 439.45 | 263.67 | 234.38 |
| P & L Balance carried down | 20,090.40 | 18,348.87 | 16,660.97 | 15,864.14 | 14,671.41 |
| Dividend | 0.00 | 263.66 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 450.00 | 750.00 | 900.00 | 400.00 |
| Dividend Per Share(Rs) | 0.00 | 4.50 | 7.50 | 9.00 | 4.00 |
| Earnings Per Share-Unit Curr | 30.08 | 33.35 | 21.00 | 24.83 | 53.13 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 353.55 | 336.62 | 305.75 | 292.15 | 271.80 |
| Book Value(Adj)-Unit Curr | 353.55 | 336.62 | 305.75 | 292.15 | 271.80 |